Five of the world’s biggest drugs companies have agreed to slash the price of
their anti-HIV drugs in developing countries by 85 per cent following sustained
pressure from health agencies, Third World governments and patient groups
(New ÒÁÈ˾þÃ, 29 April, p 14).
One of the companies, Glaxo Wellcome, is
cutting the price of triple drug therapy from $16 to $2 a day. But
pressure groups have warned that even at these prices, poverty and a lack of
health infrastructure in poor countries will mean the benefits are limited.
To continue reading, today with our introductory offers
Advertisement
More from New ÒÁÈ˾þÃ
Explore the latest news, articles and features
Popular articles
Trending New ÒÁÈ˾þà articles
1
A volcano has erupted remnants of Earth's primordial magma ocean
2
How some people's brains make an extraordinary recovery from stroke
3
The 4 must-watch science-fiction films of the year so far
4
The weirdness of neutrinos could completely rewrite particle physics
5
Random wobbles in time could finally solve gravity’s greatest mystery
6
Orangutan mothers seem to plan playdates for their offspring
7
June heatwave may have killed around 20,000 people in Europe
8
‘Hobbit’ hominins scavenged meat left over by Komodo dragons
9
The world's fastest spider tops 3.5 metres per second
10
A type of fibre that stimulates GLP-1 release approved for use in food
